SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is facing a sharp sell-off despite reporting record revenue and a double-digit income increase, as investors express frustration over management's steady guidance and perceived lack of share price momentum. The community remains deeply divided, with some investors viewing the price drop as a generational buying opportunity while others argue that the company is struggling with an identity crisis as a hybrid bank and tech platform.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood shares are under significant pressure following a fiscal quarter that missed analyst expectations, driven largely by a sharp decline in crypto-related revenue. Community sentiment is deeply divided, with some investors aggressively buying the dip on the belief that recent product diversification and strong platform engagement provide a long-term foundation, while critics point to cooling growth and lingering mistrust stemming from past platform controversies.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is trending as investors aggressively bet on the company to solve critical power constraints for AI data centers, fueled by blowout earnings and expanded hyperscaler partnerships. The community remains highly focused on the firm's role as a primary energy provider for massive infrastructure projects, with active debates centering on whether the stock's valuation is fully justified by this parabolic growth or if it risks a significant retracement.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as investors rally around its significant expansion into India's AI infrastructure, highlighted by a major multi-billion dollar GPU deployment project. The community is actively debating the stock's long-term growth potential in the AI sector while simultaneously expressing frustration over the lack of consistent management communication and guidance.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is seeing heightened market attention driven by its role in securing domestic mineral supply chains and active community speculation regarding potential government contracts and production updates. Investors are closely monitoring volume patterns while debating the stock's positioning against industry peers amidst broader concerns about market manipulation and short-selling activity.

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

Edesa Biotech Inc

Edesa Biotech is trending as investors actively discuss the risk of share dilution and the impact of a pending shareholder vote to increase equity incentive plan shares, while simultaneously weighing the potential for a strategic acquisition driven by its clinical-stage pipeline. The community remains polarized, with some speculating on a buyout and others expressing frustration over the company's capital-intensive trial requirements and historical volatility.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as investors digest the completion of its $175 million merger with defense prime contractor Mistral and a bolstered $457 million backlog, even as the stock faces volatile price action and ongoing community debate over institutional accumulation versus shareholder dilution. The broader conversation is dominated by contrasting sentiment, with some traders highlighting the company's strategic positioning in the high-growth autonomous defense sector while others remain skeptical due to its recent lack of major new contract announcements.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is facing a sharp sell-off following news that major stakeholder Pentwater Capital dumped millions of shares, sparking intense community debate over whether the stock's recent volatility represents a managed exit by hedge funds or an opportunity for a renewed short squeeze. Investors are heavily focused on the company's precarious debt levels and the potential for upcoming share offerings as they await the earnings report.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology is experiencing a significant surge driven by record financial results, a strong beat-and-raise outlook, and escalating demand for high-capacity data storage fueled by hyperscale AI infrastructure. The community is actively debating the sustainability of this rally as price targets soar, with many investors weighing the long-term potential of structural AI growth against concerns over high valuations and potential profit-taking.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is currently facing heightened volatility as investors weigh conflicting market signals, including a lawsuit from the New York Attorney General regarding prediction markets and anticipation surrounding the Clarity Act. While the community remains deeply divided between those viewing the stock as a prime long-term crypto proxy and others aggressively shorting the shares amid ongoing regulatory uncertainty, trading volume continues to be heavily influenced by fluctuations in Bitcoin prices and broader institutional sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SNTI asked 5.5 why the holding co restructuring: 
 
My ranked speculation 
 
If I had to rank the explanations: 
 
Most likely: corporate cleanup + future flexibility after prior financings and governance changes. 
 
Also likely: preserving current financing tools while eliminating stale Chardan-related overhang. 
 
Very plausible: preparing for strategic partnership, acquisition, subsidiary-level transaction, or platform/asset separation. 
 
Possible but not proven: setting up for a larger corporate event later in 2026, such as a financing, merger, licensing transaction, or restructuring around one asset. 
 
Least supported by the filing: immediate buyout or imminent acquisition. Nothing in the 8-K directly points to that. 
 
My overall read: this looks like preparatory corporate housekeeping by a small biotech that wants maximum optionality. It is not itself value-creating, but it could be a necessary step before something more meaningful — especially financing, partnership, or strategic-transaction activity.

Zannouman

StockTwits Web

Senti Biosciences Inc.

 asked 5.5 why the holding co restructuring: 
 
My ranked speculation 
 
If I had to rank the explanations: 
 
Most likely: corporate cleanup + future flexibility after prior financings and governance changes. 
 
Also likely: preserving current financing tools while eliminating stale Chardan-related overhang. 
 
Very plausible: preparing for strategic partnership, acquisition, subsidiary-level transaction, or platform/asset separation. 
 
Possible but not proven: setting up for a larger corporate event later in 2026, such as a financing, merger, licensing transaction, or restructuring around one asset. 
 
Least supported by the filing: immediate buyout or imminent acquisition. Nothing in the 8-K directly points to that. 
 
My overall read: this looks like preparatory corporate housekeeping by a small biotech that wants maximum optionality. It is not itself value-creating, but it could be a necessary step before something more meaningful — especially financing, partnership, or strategic-transaction activity.

InflaRx N.V.

Vivos Therapeutics Inc

Ed Sanchez

@EdV3 heres why am adding  the dip: if stays above 1 for next 4 days, then RS issue is done for now. Fda feedback plus durability data is expected sometime this year. If durability holds or improves then a big pharma will take em, no doubt. But note they may wanna buy just 202 . Now gene circuit and solid tumor pipeline stays with senti. If 202 fails , then they still got gene circuit . Big boys celadon bayer nea aint sold a thing yet , i feel like this could be next fourty seven inc kind of story. 5.50 was 52 week low, got acquired for 95/share.

StockTwits For Android 

 heres why am adding  the dip: if stays above 1 for next 4 days, then RS issue is done for now. Fda feedback plus durability data is expected sometime this year. If durability holds or improves then a big pharma will take em, no doubt. But note they may wanna buy just 202 . Now gene circuit and solid tumor pipeline stays with senti. If 202 fails , then they still got gene circuit . Big boys celadon bayer nea aint sold a thing yet , i feel like this could be next fourty seven inc kind of story. 5.50 was 52 week low, got acquired for 95/share.

Theriva Biologics Inc

Cango Inc.

Myseum.AI Inc.

Incannex Healthcare Limited - ADR

Clearmind Medicine Inc

@Moneypa Reasonable thesis....worth also mentioning FDA feedback on the registrational trial design is critical...if they agree to a single arm that greatly expedites time to potential BLA submission. Cash is running very low so they are going to need to figure out some type of financing; hopefully non-dilutive. This one is a real sleeper.

 Reasonable thesis....worth also mentioning FDA feedback on the registrational trial design is critical...if they agree to a single arm that greatly expedites time to potential BLA submission. Cash is running very low so they are going to need to figure out some type of financing; hopefully non-dilutive. This one is a real sleeper.